Evidence map›Paper›PMID 42253801›Full record

ArticleGeneral psychiatry2026

Development and validation of a Cog-Free risk predicting tool for dementia in a community setting.

Jiwen Che, Na Liu, Guirong Cheng, Lu Liu, Yu Luo, Juan Zhou, Ming Chen, Wen Zhou, Dan Liu, Feifei Hu and 10 more

Abstract read
In one paragraph

Article in General psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jiwen CheGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Na LiuGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Guirong ChengGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Lu LiuGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Yu LuoGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Juan ZhouWuhan Asia Heart Hospital School of Medicine Wuhan University of Science and Technology Wuhan Hubei China.
Ming ChenGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Wen ZhouGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Dan LiuGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Feifei HuGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Xinyan XieGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Xiaochang LiuGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Yuanyuan PengGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Yueyi ZhangGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Zhiming WangGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Congxia LiGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Heqianxi DongGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Chenying ZhangGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Wei TanGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.
Yan ZengGeriatric Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dementia poses a growing global public health burden, particularly in low- and middle-income countries where cognitive screening coverage remains limited. Current risk estimation tools often depend on cognitive testing or biomarkers, restricting their applicability in community and primary care settings. Aims: To establish and validate a data-driven analytical framework for developing a cognitive-testing-free dementia risk estimation tool (Cog-Free) using routinely collected health examination data. Methods: For this prospective cohort study, we developed Cog-Free, an internet-based dementia risk estimation tool, using 38 Least Absolute Shrinkage and Selection Operator-selected risk-associated variables and the optimal machine-learning algorithm (logistic regression). The optimal algorithm was internally validated with bootstrap resampling and externally tested in the Chinese Longitudinal Healthy Longevity Survey cohort. The tool was trained and internally validated in 2962 dementia-free adults aged ≥ 65 years (2018-2024), and its performance was compared with three established cognitive-testing-free tools. Results: Cog-Free achieved the highest area under the receiver operating characteristics curve in the internal validation set (0.86 [95% confidence interval (CI) 0.82-0.89]) with an accuracy of 0.81 (95% CI 0.78-0.83), sensitivity 0.78 (95% CI 0.68-0.85) and specificity 0.81 (95% CI 0.78-0.84), significantly outperforming three existing tools (DeLong's test, Conclusions: Cog-Free provides a data-driven, cognitive-testing-free and easily accessible approach for early dementia risk screening using routine health data. Its performance and web-based design suggest potential utility as a pre-screening and risk stratification tool within community health systems, including settings with limited access to cognitive testing.

Indexed as

cognitioncohort studiescommunity health servicesfollow‐up studies

Identifiers

PMID42253801
PMCPMC13240457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.